Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Eng-Hui ChewArne Holmgren

Abstract

Novel heteroaromatic-substituted 4-hydroxycyclohexa-2,5-dienones (quinols) demonstrate potent in vitro antiproliferative activity and in vivo antitumor activity in tumor xenografts. The mechanism of action of these promising novel anticancer agents, however, remains to be fully elucidated. The thioredoxin (Trx) system comprising Trx, thioredoxin reductase (TrxR), and NADPH participates in a broad range of cellular functions involved in cell survival and proliferation. Accumulating evidence has indicated that the selenocysteine-containing mammalian TrxR is a valid molecular target for development of novel cancer therapeutics. In this study, we demonstrate that structural analogs containing a quinol pharmacophore inhibited TrxR with potencies correlated with their antiproliferative and cytotoxic efficacies. Benzenesulfonyl-6F-indole-substituted quinol (compound 6) irreversibly inhibited TrxR most strongly with a half-maximal inhibitory concentration of 2.7 microM after 1 h of incubation with recombinant rat TrxR. The inhibition was shown to be concentration-, time-, and NADPH-dependent and mediated through a direct quinol attack on the penultimate C-terminal selenocysteine residue. Moreover, TrxR activity in lysates of HCT 116 ce...Continue Reading

References

Jan 1, 1995·Methods in Enzymology·A Holmgren, M Björnstedt
Oct 2, 1995·FEBS Letters·P Y GasdaskaG Powis
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·T Tamura, T C Stadtman
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·V N GladyshevT C Stadtman
Jan 1, 1996·Annual Review of Biochemistry·T C Stadtman
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·S N Gorlatov, T C Stadtman
Jul 25, 1998·The Biochemical Journal·S GromerK Becker
Sep 30, 2000·European Journal of Biochemistry·E S Arnér, A Holmgren
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A T Dinkova-KostovaP Talalay
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·Q A SunV N Gladyshev
Apr 18, 2001·International Journal of Cancer. Journal International Du Cancer·K KahlosV L Kinnula
Jun 19, 2001·International Journal of Cancer. Journal International Du Cancer·U Törmänen-NäpänkangasP Pääkkö
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SandalovaG Schneider
Feb 7, 2003·Journal of Medicinal Chemistry·Geoffrey WellsMalcolm F G Stevens
Jul 25, 2003·The Journal of Laboratory and Clinical Medicine·Jennifer RaffelGarth Powis
Nov 5, 2003·Medicinal Research Reviews·Stephan GromerKatja Becker
Nov 8, 2003·The Journal of Biological Chemistry·Narimantas CenasElias S J Arnér
Oct 16, 2004·Molecular and Cellular Biology·Marcus ConradMarkus Brielmeier
Feb 17, 2005·Molecular and Cellular Biology·Cemile JakupogluMarcus Conrad
May 4, 2005·Cancer Research·Tracey D BradshawMalcolm F G Stevens
Oct 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ekaterina I BiterovaJoseph J Barycki
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seung Jin KimShinzaburo Noguchi
Feb 17, 2006·The Journal of Biological Chemistry·Seyed Isaac HashemyArne Holmgren
Mar 28, 2006·The Journal of Biological Chemistry·Min-Hyuk YooDolph L Hatfield
Jun 8, 2006·Biochemical and Biophysical Research Communications·Eng-Hui ChewTracey D Bradshaw
Aug 16, 2006·Bioorganic & Medicinal Chemistry Letters·Cedric J LionAndrew D Westwell
Oct 24, 2006·Seminars in Cancer Biology·Sabine Urig, Katja Becker
Nov 10, 2006·Seminars in Cancer Biology·Elias S J Arnér, Arne Holmgren
Nov 23, 2006·Antioxidants & Redox Signaling·Christopher Horst Lillig, Arne Holmgren

❮ Previous
Next ❯

Citations

Dec 2, 2011·Journal of Medicinal Chemistry·Szymon KłossowskiRyszard Ostaszewski
Jan 8, 2011·The Journal of Biological Chemistry·Janine KönigAlan H Fairlamb
Jun 6, 2009·Antioxidants & Redox Signaling·Georg T Wondrak
Jul 23, 2009·Antioxidants & Redox Signaling·Michika MochizukiHiroshi Masutani
Sep 22, 2009·Antioxidants & Redox Signaling·Meihua LuoMillie M Georgiadis
Apr 9, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jun LuArne Holmgren
Jan 9, 2014·Inorganic Chemistry·Zahra AlmodaresPatrick C McGowan
Apr 20, 2010·Organic & Biomolecular Chemistry·Andrew J McCarrollMalcolm F G Stevens
Mar 18, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Wei ChenXiangming Guan
Sep 17, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Tanu ChamoliMelissa Jacob
Nov 9, 2011·Free Radical Biology & Medicine·Wenqing CaiJianguo Fang
Jul 6, 2010·European Journal of Pharmacology·Daphne Pei Wen WongThilo Hagen
Mar 26, 2014·Chemical Research in Toxicology·Yi-Hua JanJeffrey D Laskin
Jul 29, 2009·Biochemical and Biophysical Research Communications·Fei Fei GanThilo Hagen
Jan 24, 2012·Bioorganic & Medicinal Chemistry·Amy CapesIan H Gilbert
Jun 11, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Jianming LiaoYuanyuan Lu
Dec 19, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jun LuArne Holmgren
Apr 20, 2018·ACS Medicinal Chemistry Letters·Anupama Tuladhar, Kathleen S Rein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis